Close Menu

Boreal Genomics

The company no longer plans to develop cell-free DNA assays for oncology but will instead look to commercialize a new target capture technology.

The Pro-Seq technology links molecules prior to sequencing to enable detection of low-frequency variants, and could be complementary to Boreal's OnTarget technology.

The companies will co-develop kits, which Trovagene will distribute globally, to analyze ctDNA from blood or urine using next-generation sequencing platforms.

Over the last two years, the Vancouver, British Columbia-based company has been offering the assay as a service to academic and pharmaceutical researchers.

NEW YORK (GenomeWeb News) – Boreal Genomics said today that it has completed an $18 million Series C financing round, which will be used to expand its commercial operations and launch clinical applications.

Peter Rogan has been awarded US Patent No. 8,532,934, "Rapid and comprehensive identification of prokaryotic organisms by metagenomic analysis."

This article has been updated to correct that cell-free DNA, not plasma, is injected into the cartridge.

Boreal Genomics now has reusable cartridges for its Aurora Nucleic Acid Extraction System. The cartridges are provided with gel casting accessories and can be refilled many times in order to reduce per-sample purification costs.

Boreal Genomics has launched an early access program for its OnTarget Allele Enrichment System, which depletes wild-type alleles to improve detection of known and unknown rare cancer mutations.

Agilent Technologies has launched SureSelect XT Human Methyl-Seq and HaloPlex target enrichment systems.

Pages

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.